Back to results
RecruitingPhase 2

Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients

NCT04159818

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Antoni van Leeuwenhoek

Amsterdam, Netherlands

Contact

Marleen Kok, MD

+3120 512m.kok@nki.nl
View on ClinicalTrials.gov
Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients — TrialFind